News
In myasthenia gravis, complement plays a big role in what happens to the muscle end of the neuromuscular junction, explains ...
Zacks Investment Research on MSN20h
RARE's GTX-102 Gets FDA's Breakthrough Status for Angelman SyndromeUltragenyx Pharmaceuticals RARE announced that the FDA has granted the Breakthrough Therapy designation to its ...
The Food and Drug Administration has approved Harliku (nitisinone) for the reduction of urine homogentisic acid in adult patients with alkaptonuria.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback